Birth control

3Daughters Announces Three New Appointments to Board of Directors

Retrieved on: 
Wednesday, March 13, 2024
Quotient, Thakeham, Alnylam Pharmaceuticals, CDMO, Birth, Labs, GSK plc, Pharmacy, University, Novartis, Dana–Farber Cancer Institute, IUD, University College London, Embryology, IND, MBA, Woman, Doctor of Philosophy, Intrauterine device, Therapy, Drug development, Allergan, Amersham plc, Takeda Oncology, Chief Justice of Hungary, Pharmacia, Birth control

Miles, Ph.D., and Sarah J. Stevens, Ph.D., to serve on the Company’s Board of Directors.

Key Points: 
  • Miles, Ph.D., and Sarah J. Stevens, Ph.D., to serve on the Company’s Board of Directors.
  • An IND for 3D-001 will be filed this year followed by a Phase 1 clinical trial.
  • Mary Beth Cicero, CEO of 3Daughters, expressed her enthusiasm about the new additions to the board: "We are incredibly excited to have the collective strengths of Michele, Sarah, and Vin on our Board of Directors.
  • With this first product, 3Daughters expects to disrupt the IUD market and establish a position as a major innovator in women's healthcare.

Empowering Mothers Everywhere: Momcozy Debuts Its Momcozy Care Program

Retrieved on: 
Tuesday, March 12, 2024
Mother, Organization, Partnership, Pregnancy, City, Nursing, Consultant, Parent, Birth control

LONDON, March 12, 2024 (GLOBE NEWSWIRE) -- A companion to three million moms from pregnancy through early motherhood, global maternity brand Momcozy has introduced the Momcozy Care Program , a comprehensive initiative aimed at providing real support to mothers at every stage of their journey.

Key Points: 
  • LONDON, March 12, 2024 (GLOBE NEWSWIRE) -- A companion to three million moms from pregnancy through early motherhood, global maternity brand Momcozy has introduced the Momcozy Care Program , a comprehensive initiative aimed at providing real support to mothers at every stage of their journey.
  • The program, built on Momcozy’s foundation of putting moms first, offers a holistic approach to care.
  • Momcozy emphasizes the significance of collaboration with impactful organizations, institutions and professionals in achieving positive maternity outcomes.
  • Through The Baby Academy, Momcozy supports access to free, evidence-based breastfeeding education via the Breastfeeding Preparation Class conducted by Internationally Board Certified Lactation Consultants.

Rite Aid Announces Availability of Opill at All Locations

Retrieved on: 
Thursday, April 4, 2024
General Health, Health, Retail, Pharmaceutical, Convenience Store, Pregnancy, Senior, Woman, Rite Aid, FDA, Pharmacist, OTC, Birth control

Rite Aid Corporation (OTC: RADCQ) today announced Opill, the first daily oral contraceptive FDA-approved for purchase without a prescription, is now available in all stores.

Key Points: 
  • Rite Aid Corporation (OTC: RADCQ) today announced Opill, the first daily oral contraceptive FDA-approved for purchase without a prescription, is now available in all stores.
  • Opill over-the-counter birth control pills are available at Rite Aid for the suggested retail price of $19.99 for a one-month supply and $49.99 for a three-month supply.
  • “Rite Aid remains committed to providing convenient access to customers for all of their health and wellness needs.”
    There are no restrictions for purchasing Opill.
  • Rite Aid pharmacists are available to answer any customer questions about Opill.

First Fertility Partners with Fertility & Surgical Associates of California, expanding its nationwide footprint into Southern California

Retrieved on: 
Tuesday, April 2, 2024
Women, General Health, Health, Parenting, Family, Baby, Maternity, Consumer, LGBTQ+, Partnership, Physician, Fertility, First, Birth control

First Fertility , one of the largest fertility networks in the United States is proud to announce that Fertility & Surgical Associates of California , a fertility practice internationally recognized as a leader in advanced fertility treatment, has joined the First Fertility network.

Key Points: 
  • First Fertility , one of the largest fertility networks in the United States is proud to announce that Fertility & Surgical Associates of California , a fertility practice internationally recognized as a leader in advanced fertility treatment, has joined the First Fertility network.
  • This partnership expands the First Fertility footprint into Southern California, adding three locations in Thousand Oaks, Encino and Santa Monica, featuring four double-board certified fertility specialist physicians: Richard Buyalos, MD; Gary Hubert, MD; Holly Mehr, MD; and Mousa Shamonki, MD.
  • By offering the ideal combination of medical expertise and a personalized patient experience every step of the way, the addition of Fertility & Surgical Associates of California (FSAC) to the First Fertility family of centers furthers the First Fertility vision to exceed the standard of fertility care in every community that we serve.
  • “As CEO, I'm thrilled to welcome this outstanding team of physicians and staff to First Fertility,” said Cara Reymann, CEO of First Fertility.

Navigating Spring Break Sexual Health: Advice from Dr. Deb Laino Sex and Relationship Therapist and Powerful Life Coach

Retrieved on: 
Friday, March 29, 2024
Men, General Health, LGBTQ+, Online Retail, Lifestyle, Discount, Variety, Specialty, Consumer, Convenience Store, Catalog, Retail, Women, Health, Communication, Birth, Relaxation, Condom, Intuition, Travel, Knowledge, STI, Trojan, Safety, Lubricant, Birth control

Prioritizing discussions surrounding sexual health, including consent, boundaries, contraception, STI prevention, and overall sexual well-being is crucial.

Key Points: 
  • Prioritizing discussions surrounding sexual health, including consent, boundaries, contraception, STI prevention, and overall sexual well-being is crucial.
  • Dr. Deb Laino, Sex and Relationship Therapist and Powerful Life Coach, is shedding light on spring break sexual health, emphasizing the importance of informed decision-making, open communication, protection and more.
  • "Spring break is a time of liberation and exploration for many individuals, so it's important not to overlook the significance of sexual health amidst all the excitement," says Laino.
  • Below, Dr. Deb Laino offers the following advice for prioritizing sexual health on spring break.

Navigating Birth Control: Expert Advice from Dr. Bana Kashani, OB-GYN

Retrieved on: 
Friday, March 29, 2024
Women, Other Communications, Baby, Maternity, Communications, Practice Management, Family, Health, Consumer, General Health, Birth, Pregnancy, Infertility, Q&A, Intrauterine device, Condom, Menstrual cycle, Sterilization, IUD, Ovulation, Research, Fertility, Pelvic inflammatory disease, Hormonal contraception, Tubing (recreation), STI, Woman, USB On-The-Go, Birth control

In a rapidly evolving landscape of reproductive health, navigating the variety of birth control options can be overwhelming.

Key Points: 
  • In a rapidly evolving landscape of reproductive health, navigating the variety of birth control options can be overwhelming.
  • “When choosing a birth control method, it's essential to consider factors such as efficacy, convenience, side effects, and personal preferences.
  • Dr. Kashani sheds light on various birth control methods in the following Q&A:
    What are the different types of birth control methods available?
  • There is limited evidence to suggest that using birth control methods for an extended period negatively impacts fertility.

Cadence OTC Announces Community Investment Campaign to Support the Movement for Accessible Birth Control in Post-Roe America

Retrieved on: 
Thursday, March 28, 2024
Teens, Women, FDA, Convenience Store, Other Health, Health, Consumer, Pharmaceutical, Retail, Birth, Woman, Condom, Partnership, George Soros, Education, 7-Eleven, MAP, OTC, Food, Birth control

Cadence OTC , a pioneering public benefits consumer healthcare company, has passionately pursued the vision of accessible over-the-counter (OTC) birth control pills.

Key Points: 
  • Cadence OTC , a pioneering public benefits consumer healthcare company, has passionately pursued the vision of accessible over-the-counter (OTC) birth control pills.
  • The campaign invites the public to champion affordable, accessible birth control and make a heartfelt investment in women's reproductive autonomy.
  • Samantha Miller, co-founder and co-CEO of Cadence OTC, asserts, “Birth control should be as easy to buy as condoms.
  • To be part of this historic movement in reproductive care and for more information on Cadence OTC, visit https://wefunder.com/cadenceotc/ .

China In-Vitro Fertilization Market Research Report 2023-2030 Featuring Vitrolife, Cloudnine, Nova IVI Fertility, Monash, Maria Fertility Hospital, Bangkok Fertility Center, and EMD Serono - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
General Health, Other Health, Consumer, Health, Baby, Maternity, Consciousness, Infertility, Prevalence, IVF, Sterilization, Fertility, Fertilisation, Woman, Male, Infection, Patient safety, ICSI, Birth control

Economic improvement has fueled a terrific increase in the China in-vitro Fertilization (IVF) market.

Key Points: 
  • Economic improvement has fueled a terrific increase in the China in-vitro Fertilization (IVF) market.
  • Disposable devices are predicted to be among the instruments used considerably in the China In-Vitro Fertilization (IVF) market.
  • ICSI IVF is foreseen to be among the considerably utilized processes in the China In-Vitro Fertilization (IVF) market.
  • Fertility clinics are projected to experience a considerable increase in utilization in the China In-Vitro Fertilization (IVF) market.

Cadence OTC Revolutionizes Access to Emergency Contraception with NEW Morning After Pill™, Now Available in Convenience Stores Nationwide

Retrieved on: 
Tuesday, March 19, 2024
Men, Other Health, General Health, Family, Pharmaceutical, Discount, Variety, Consumer, Convenience Store, Teens, Parenting, Retail, Women, Health, Partnership, ECS, Emergency contraception, Woman, FDA, Female, Food, Condom, Birth control

Cadence OTC , a Public Benefits consumer healthcare company, is redefining access to emergency contraception (EC) with its groundbreaking initiative, making Morning After Pill™ available at convenience stores across the U.S.

Key Points: 
  • Cadence OTC , a Public Benefits consumer healthcare company, is redefining access to emergency contraception (EC) with its groundbreaking initiative, making Morning After Pill™ available at convenience stores across the U.S.
  • "C-stores are everywhere – there are more than 150,000 throughout the country, in every neighborhood, and they are open long hours.
  • This is a situation where convenience truly matters because the sooner you take it, the better it works – hours matter.
  • For more information about Cadence OTC and its mission to increase access to emergency contraceptives, please visit cadenceotc.com .

YourChoice Therapeutics Scientific Advisory Board member updates phase 1a study for male birth control candidate at ACS Spring 24

Retrieved on: 
Tuesday, March 19, 2024
Biotechnology, Other Health, Health, General Health, Healthcare Reform, Pharmaceutical, Other Science, Research, Public Policy, Government, Science, Clinical Trials, Vitamin A, Mouse, University, Doctor of Philosophy, Trial of the century, Woman, Male, Therapy, Safety, ACS, Pharmacokinetics, American Chemical Society, Birth control

YourChoice Therapeutics, a San Francisco biotech startup developing the first hormone-free male birth control pill, announced today that Gunda Georg, YCT-529’s co-inventor, provided an update on its phase 1a clinical study for the first hormone-free male birth control pill, YCT-529, at the American Chemical Society (ACS) 2024 Spring Meeting.

Key Points: 
  • YourChoice Therapeutics, a San Francisco biotech startup developing the first hormone-free male birth control pill, announced today that Gunda Georg, YCT-529’s co-inventor, provided an update on its phase 1a clinical study for the first hormone-free male birth control pill, YCT-529, at the American Chemical Society (ACS) 2024 Spring Meeting.
  • The phase 1a study investigates the safety, tolerability, pharmacokinetics, and pharmacodynamics of single, ascending oral doses of YCT-529 in 16 participants.
  • I’m pleased to be a part of that future.”
    YCT-529 is a hormone-free birth control candidate currently under investigation.
  • “Men and women want more birth control options, and they want them to be hormone-free,” said Akash Bakshi, co-founder and CEO of YourChoice Therapeutics.